Interestingly, when a dual orexin receptor antagonist, almorexant, was infused intracerebroventricularly (icv) during in vivo microdialysis for an ISF Aβ experiment, Kang et al discovered that theISF Aβ levels were suppressed and the natural diurnal variation of Aβ was also abolished